The Institute for In Vitro Sciences, Inc. (IIVS) has received first funding from Shenzhen Basixing Technology Co., Ltd., a Chinese owned and operated beauty tech company. The funding demonstrates the growing desire for non-animal test methods in China and the importance of the IIVS program to help implement them.
Shenzen Focuses on New Technologies
Shenzhen Basixing Technology (Shenzhen, China) focuses on the application of new technologies in both beauty care products and devices. Kitty Annie, Shenzhen first brand was created to meet the needs of young consumers of generation Z.
“
We are a group of young people who have strong beliefs in science, technology and art. Through the combination of active cosmetics and devices, our goal is to provide a unique beauty experience with perceivable benefits for our consumers while promoting transparency and sustainability,” stated Dr. Zhi Pan, chief scientist at Shenzhen Basixing.
IIVS’ promotion of non-animal tests has brought real change to China and companies like Shenzhen will be able to avoid animal testing in the future.
IIVS' Lab for Animal Alternative Testing
IIVS has been working in collaboration with China’s top regulatory agency responsible for cosmetics supervision to transfer non-animal test methods through outreach and training programs. These training programs have helped to establish the national Key Laboratory for Animal Alternative Testing for Cosmetics at the Zhejiang Institute for food and drug control (Hangzhou, China).
Regulatory acceptance of these methods will allow companies to register cosmetics without animal testing in the future. Access to these methods also means that Chinese companies can export products to markets that prohibit animal testing of cosmetics, such as the European Union.
“
To date our outreach program has been funded primarily by multi-national companies. We are delighted that Shenzhen Basixing and Kitty Annie have chosen to demonstrate their commitment to non-animal testing with a contribution to our program,” said Erin Hill, president, IIVS.
Source: IIVS